Published in

Lippincott, Williams & Wilkins, Blood Coagulation and Fibrinolysis, 4(16), p. 297-299, 2005

DOI: 10.1097/01.mbc.0000169224.23550.3f

Links

Tools

Export citation

Search in Google Scholar

Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock

Journal article published in 2005 by Jesús Martínez, Ana Rosa Cid, Javier de la Rubia ORCID, Ricardo Gimeno
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Although mainly indicated for treatment of bleeding in haemophilia patients with inhibitors, recombinant activated factor VII (rFVIIa) has also been successfully used in other situations. However, no data are available on its use in the treatment of disseminated intravascular coagulation (DIC) secondary to septic shock. We report a man with DIC and septic shock due to retrocaecal appendicitis and severe intra-abdominal bleeding after surgery. Despite conventional treatment, the bleeding persisted, and treatment with rFVIIa controlled the haemorrhage. No side-effects related to rFVIIa were noted. This case suggests a potential role of rFVIIa in the treatment of severe bleeding associated with DIC.